KSM Feed

Dr. Tal Patalon in Forbes: Small-Big Data – KSM’s Healthcare Revolution.

KSM research on natural immunity.

KSM And Genetika+ Partner To Seek AI Solutions For Personalization Of Depression Treatment.

KSM and Genetika+ collaborate to advance research on depression.

Delta reinfection risk low among unvaccinated children.

KSM study: Immunity against COVID-19 among children many months after infection.

Our new study on the duration of protection conferred by a previous SARS-CoV-2 infection amongst children and adolescents.

KSM partners with PrognomiQ to improve early cancer detection.

KSM’s unique collaboration with PrognomiQ advances cancer detection.

KSM cooperation with Bahrein on prime time.

Our strategic agreement with Bahrain continues to make headlines.

KSM-Bahrain collaboration on research.

KSM signed an agreement for joint medical research with Bahrain.

Our new COVID-19 4th shot study continues to make headlines.

The 4th dose of the BNT162b2 vaccine provides at least 73% protection against SARS-CoV-2 severe illness relative to three doses.